Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation Luís Silva Miguel, Jorge Ferreira

Systematic review of cost-effectiveness analyses of novel oral anticoagulants for stroke prevention in atrial fibrillation João Ferreira, Ana Mirco

Economic evaluation of dabigatran for stroke prevention in patients with non-valvular atrial fibrillation Luís Silva Miguel, Evangelista Rocha, Jorge Ferreira